• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基线尿酸水平与急性缺血性脑卒中患者静脉溶栓治疗结局的前瞻性队列研究。

Baseline Uric Acid Levels and Intravenous Thrombolysis Outcomes in Patients With Acute Ischemic Stroke: A Prospective Cohort Study.

机构信息

Department of Epidemiology and Biostatistics, School of Public Health Jilin University Changchun China.

Stroke Center & Clinical Trial and Research Center for Stroke, Department of Neurology The First Hospital of Jilin University Changchun China.

出版信息

J Am Heart Assoc. 2024 Apr 2;13(7):e033407. doi: 10.1161/JAHA.123.033407. Epub 2024 Mar 27.

DOI:10.1161/JAHA.123.033407
PMID:38533986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11179752/
Abstract

BACKGROUND

The study aimed to investigate the relationship between uric acid (UA) levels and functional outcomes at 3 months in patients with acute ischemic stroke (AIS) who underwent intravenous thrombolysis (IVT).

METHODS AND RESULTS

This prospective cohort study included 1001 consecutive patients with AIS who underwent IVT. The correlation between UA levels and post-IVT AIS outcomes was examined. Any nonlinear relationship was assessed using a restricted cubic spline function. The nonlinear value for the association of UA levels with favorable (modified Rankin Scale [mRS] score ≤2) and excellent (mRS score ≤1) outcomes at 3 months post-IVT were <0.001 and 0.001, respectively. However, for patients with and without hyperuricemia, no evident nonlinear relationship was observed between UA levels and favorable 3-month post-IVT outcomes, with nonlinear values of 0.299 and 0.207, respectively. The corresponding interaction analysis yielded a value of 0.001, indicating significant heterogeneity. Similar results were obtained for excellent outcomes at 3 months post-IVT. In the hyperuricemia group, increased UA levels by 50 μmol/L reduced the odds of a favorable 3-month post-AIS outcome (odds ratio [OR], 0.75 [95% CI, 0.57-0.97]). Conversely, in the nonhyperuricemia group, a similar UA increase was linked to higher favorable outcome odds (OR, 1.31 [95% CI, 1.15-1.50]).

CONCLUSIONS

An inverted U-shaped nonlinear relationship was observed between UA levels and favorable and excellent outcomes at 3 months in patients with AIS who underwent IVT. Higher UA levels predict favorable outcomes in patients without hyperuricemia but unfavorable outcomes in those with hyperuricemia.

摘要

背景

本研究旨在探讨接受静脉溶栓(IVT)治疗的急性缺血性脑卒中(AIS)患者血尿酸(UA)水平与 3 个月时功能结局的关系。

方法

这是一项前瞻性队列研究,纳入了 1001 例接受 IVT 的 AIS 连续患者。研究考察了 UA 水平与 post-IVT AIS 结局之间的相关性。采用限制立方样条函数评估 UA 水平与 3 个月时预后良好(改良 Rankin 量表[mRS]评分≤2)和优秀(mRS 评分≤1)结局之间的非线性关系。非线性关系的 值分别为<0.001 和<0.001。然而,对于伴有和不伴有高尿酸血症的患者,UA 水平与 3 个月时预后良好之间未观察到明显的非线性关系,非线性 值分别为 0.299 和 0.207。对应的交互分析得出的 值为 0.001,表明存在显著的异质性。3 个月时预后优秀的结果也得出了类似的结果。在高尿酸血症组中,UA 水平升高 50μmol/L,降低了 3 个月时预后良好的可能性(比值比[OR],0.75[95%可信区间,0.57-0.97])。相反,在非高尿酸血症组中,UA 水平的类似增加与更高的预后良好可能性相关(OR,1.31[95%可信区间,1.15-1.50])。

结论

接受 IVT 治疗的 AIS 患者中,UA 水平与 3 个月时的预后良好和优秀结局之间存在倒 U 型非线性关系。UA 水平较高可预测无高尿酸血症患者的预后良好,但预测高尿酸血症患者的预后不良。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7276/11179752/f1bfd18a4e05/JAH3-13-e033407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7276/11179752/b60e9a723d54/JAH3-13-e033407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7276/11179752/48375d8e6291/JAH3-13-e033407-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7276/11179752/0c0f5d3214f5/JAH3-13-e033407-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7276/11179752/f1bfd18a4e05/JAH3-13-e033407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7276/11179752/b60e9a723d54/JAH3-13-e033407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7276/11179752/48375d8e6291/JAH3-13-e033407-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7276/11179752/0c0f5d3214f5/JAH3-13-e033407-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7276/11179752/f1bfd18a4e05/JAH3-13-e033407-g001.jpg

相似文献

1
Baseline Uric Acid Levels and Intravenous Thrombolysis Outcomes in Patients With Acute Ischemic Stroke: A Prospective Cohort Study.基线尿酸水平与急性缺血性脑卒中患者静脉溶栓治疗结局的前瞻性队列研究。
J Am Heart Assoc. 2024 Apr 2;13(7):e033407. doi: 10.1161/JAHA.123.033407. Epub 2024 Mar 27.
2
The prognostic value of combined uric acid and neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis.血尿酸与中性粒细胞与淋巴细胞比值联合对接受静脉溶栓治疗的急性缺血性脑卒中患者的预后价值。
BMC Neurol. 2024 May 31;24(1):183. doi: 10.1186/s12883-024-03628-w.
3
Predictive value of fibrinogen levels for 90-day functional outcomes after intravenous thrombolysis in patients with acute ischaemic stroke.纤维蛋白原水平对急性缺血性脑卒中患者静脉溶栓后90天功能结局的预测价值。
J Clin Neurosci. 2023 May;111:6-10. doi: 10.1016/j.jocn.2023.02.019. Epub 2023 Mar 8.
4
Neutrophil-to-lymphocyte ratio and its changes predict the 3-month outcome and mortality in acute ischemic stroke patients after intravenous thrombolysis.中性粒细胞与淋巴细胞比值及其变化可预测急性缺血性脑卒中患者静脉溶栓后 3 个月的结局和死亡率。
Brain Behav. 2023 Sep;13(9):e3162. doi: 10.1002/brb3.3162. Epub 2023 Jul 20.
5
Early tirofiban administration for patients with acute ischemic stroke treated with intravenous thrombolysis or bridging therapy: Systematic review and meta-analysis.早期替罗非班给药用于接受静脉溶栓或桥接治疗的急性缺血性脑卒中患者:系统评价和荟萃分析。
Clin Neurol Neurosurg. 2022 Nov;222:107449. doi: 10.1016/j.clineuro.2022.107449. Epub 2022 Sep 21.
6
Associations between Uric Acid Level and 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with/without Edaravone.使用/未使用依达拉奉治疗的急性缺血性中风患者尿酸水平与3个月功能结局之间的关联
Cerebrovasc Dis. 2018;45(3-4):115-123. doi: 10.1159/000488038. Epub 2018 Mar 20.
7
Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta-Analysis.近期直接口服抗凝药物使用患者的急性缺血性脑卒中的静脉溶栓治疗:系统评价和荟萃分析。
J Am Heart Assoc. 2023 Dec 19;12(24):e031669. doi: 10.1161/JAHA.123.031669. Epub 2023 Dec 18.
8
Predictive value of serum MDA and 4-HNE levels on the occurrence of early neurological deterioration after intravenous thrombolysis with rt-PA IVT in patients with acute ischemic stroke.急性缺血性脑卒中患者静脉注射重组组织型纤溶酶原激活剂(rt-PA)进行静脉溶栓后,血清丙二醛(MDA)和4-羟基壬烯醛(4-HNE)水平对早期神经功能恶化发生的预测价值。
J Stroke Cerebrovasc Dis. 2024 Apr;33(4):107574. doi: 10.1016/j.jstrokecerebrovasdis.2024.107574. Epub 2024 Jan 11.
9
Short- and long-term mortality after intravenous thrombolysis for acute ischemic stroke: A propensity score-matched cohort with 5-year follow-up.急性缺血性脑卒中静脉溶栓后短期和长期死亡率:5 年随访的倾向性评分匹配队列研究。
Medicine (Baltimore). 2021 Nov 5;100(44):e27652. doi: 10.1097/MD.0000000000027652.
10
Mechanical thrombectomy combined with intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analyses.机械取栓联合静脉溶栓治疗急性缺血性脑卒中的系统评价和荟萃分析。
Sci Rep. 2023 May 26;13(1):8597. doi: 10.1038/s41598-023-35532-7.

引用本文的文献

1
Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study.急性缺血性卒中患者静脉注射重组组织型纤溶酶原激活剂(r-tPA)后3个月功能预后的结局及危险因素:一项回顾性队列研究
Thromb J. 2025 Mar 10;23(1):21. doi: 10.1186/s12959-025-00704-0.
2
Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases.靶向尿酸:一种针对神经退行性疾病中氧化应激和神经炎症的有前景的干预措施。
Cell Commun Signal. 2025 Jan 3;23(1):4. doi: 10.1186/s12964-024-01965-4.
3
A New Perspective on the Prediction and Treatment of Stroke: The Role of Uric Acid.

本文引用的文献

1
The potential role of insulin resistance in predicting outcome from intravenous thrombolytic therapy.胰岛素抵抗在预测静脉溶栓治疗结果中的潜在作用。
Acta Neurol Belg. 2023 Jun;123(3):885-892. doi: 10.1007/s13760-022-02060-6. Epub 2022 Aug 20.
2
Lower uric acid level may be associated with hemorrhagic transformation after intravenous thrombolysis.尿酸水平降低可能与静脉溶栓后出血性转化有关。
Neurol Sci. 2022 May;43(5):3113-3120. doi: 10.1007/s10072-021-05760-8. Epub 2021 Nov 24.
3
Higher uric acid is associated with better discharge recovery and short-term outcome in stroke patients treated with thrombolysis.
中风预测与治疗的新视角:尿酸的作用
Neurosci Bull. 2025 Mar;41(3):486-500. doi: 10.1007/s12264-024-01301-3. Epub 2024 Sep 23.
尿酸水平升高与溶栓治疗的脑卒中患者出院后恢复情况更好和短期预后更好相关。
Neurol Sci. 2021 Aug;42(8):3225-3231. doi: 10.1007/s10072-020-04919-z. Epub 2020 Nov 25.
4
Prognostic significance of uric acid change in acute ischemic stroke patients with reperfusion therapy.尿酸变化对急性缺血性脑卒中再灌注治疗患者预后的意义。
Eur J Neurol. 2021 Apr;28(4):1218-1224. doi: 10.1111/ene.14643. Epub 2020 Dec 1.
5
The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis: Results From SITS Registry.溶栓后早期神经功能恶化的发生率及相关因素:来自 SITS 登记的结果。
Stroke. 2020 Sep;51(9):2705-2714. doi: 10.1161/STROKEAHA.119.028287. Epub 2020 Aug 19.
6
[Practice guideline for patients with hyperuricemia/gout].[高尿酸血症/痛风患者的实践指南]
Zhonghua Nei Ke Za Zhi. 2020 Jul 1;59(7):519-527. doi: 10.3760/cma.j.cn112138-20200505-00449.
7
Uric acid therapy for vasculoprotection in acute ischemic stroke.急性缺血性卒中血管保护的尿酸治疗
Brain Circ. 2019 Apr-Jun;5(2):55-61. doi: 10.4103/bc.bc_1_19. Epub 2019 Jun 27.
8
Hyperuricemia and prognosis of acute ischemic stroke in diabetic patients.糖尿病患者高尿酸血症与急性缺血性卒中的预后
Neurol Res. 2019 Mar;41(3):250-256. doi: 10.1080/01616412.2018.1553347. Epub 2018 Dec 11.
9
U-Shaped Relationship Between Functional Outcome and Serum Uric Acid in Ischemic Stroke.缺血性卒中功能结局与血清尿酸之间的U型关系
Cell Physiol Biochem. 2018;47(6):2369-2379. doi: 10.1159/000491609. Epub 2018 Jul 10.
10
Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy.自由基损伤在缺血再灌注损伤中的作用:血管再通治疗后急性缺血性脑卒中的障碍。
Oxid Med Cell Longev. 2018 Jan 31;2018:3804979. doi: 10.1155/2018/3804979. eCollection 2018.